NVO - Wall Street Estimates - Novo Nordisk A/S

Healthcare - Biotechnology - NYSE - DK

$ 85.1

-0.281 %

$ 372 B

Market Cap

28.75

P/E

Price Target Average

87.03%

Revenue Forecast Estimate

29.30%

EBIT Estimate

27.30%

Net Income Estimate

32.41%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Novo Nordisk A/S

Wall Street analysts predict an average 1-year price target for NVO of $159 , with forecasts ranging from a low of $156 to a high of $163 .

NVO Lowest Price Target Wall Street Target

156 USD 83.31%

NVO Average Price Target Wall Street Target

159 USD 87.03%

NVO Highest Price Target Wall Street Target

163 USD 91.54%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free